Showing results (661-670 of 694) with videos related to

Sort By:
Pageof 70
Bone Marrow Transplantation|July 20, 2026
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia?F Baleydier, J E Galimard, F Bernard, et al.
Haematologica|June 28, 2000
Hematopoietic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)A Pession, R Rondelli, P Paolucci, et al.
Oncogene|August 29, 2006
Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registryA Acquaviva, L Ciccolallo, R Rondelli, et al.
Clinical Kidney Journal|March 28, 2015
Optimization of the convection volume in online post-dilution haemodiafiltration: practical and technical issuesIsabelle Chapdelaine, Camiel L M de Roij van Zuijdewijn, Ira M Mostovaya, et al.
Leukemia|December 7, 2017
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocolE M C Driessen, P de Lorenzo, M Campbell, et al.
Bone Marrow Transplantation|March 20, 2026
Impact of acute GvHD severity on survival and disease relapse in pediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia: an analysis based on the EBMT-PDWP registryZ Szmit, G Lucchini, A Bertaina, et al.
Leukemia|January 8, 2011
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 studyB Strahm, P Nöllke, M Zecca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in ChildhoodF Locatelli, C Niemeyer, E Angelucci, et al.
British Journal of Haematology|June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg, M Rabusin, M Musso, et al.
Leukemia|November 21, 2019
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemiaC Quintarelli, S Sivori, S Caruso, et al.
Pageof 70